Item 9 Labs Corp (INLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 06-2018 | |
| Sales | 1,306 | 1,542 | 1,130 | 956 | 440 |
| Cost of Goods | 853 | 698 | 529 | 476 | 377 |
| Gross Profit | 453 | 844 | 601 | 479 | 63 |
| Operating Expenses | 9,428 | 2,356 | 1,936 | 1,354 | 825 |
| Operating Income | -8,122 | -814 | -806 | -399 | -385 |
| Interest Expense | 320 | 21 | 1 | 1 | 1 |
| Other Income | 353 | 135 | 26 | 22 | 5 |
| Pre-tax Income | -8,089 | -701 | -781 | -377 | -380 |
| Income Tax | N/A | 157 | 115 | N/A | N/A |
| Net Income Continuous | -7,818 | -857 | -896 | -377 | -380 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 35 |
| Minority Interests | -56 | -7 | -12 | -49 | N/A |
| Net Income | $-7,762 | $-851 | $-884 | $-329 | $-345 |
| EPS Basic Total Ops | -0.13 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.13 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.13 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.13 | -0.01 | -0.01 | -0.01 | -0.01 |
| EBITDA(a) | $-7,723 | $-646 | $-710 | $-386 | $-385 |